Physical performance testing in mucopolysaccharidosis I: a pilot study
Objective: To develop and field-test a physical performance measure (MPS-PPM) for individuals with Mucopolysaccharidosis I (MPS I), a rare genetic disorder. Methods: Motor performance and endurance items were developed based on literature review, clinician feedback, feasibility, and equipment and tr...
Gespeichert in:
| Veröffentlicht in: | Developmental neurorehabilitation 2004-04, Vol.7 (2), p.125-131 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 131 |
|---|---|
| container_issue | 2 |
| container_start_page | 125 |
| container_title | Developmental neurorehabilitation |
| container_volume | 7 |
| creator | Dumas, Helene M. Fragala, Maria A. Haley, Stephen M. Skrinar, Alison M. Wraith, James E. Cox, Gerald F. |
| description | Objective: To develop and field-test a physical performance measure (MPS-PPM) for individuals with Mucopolysaccharidosis I (MPS I), a rare genetic disorder. Methods: Motor performance and endurance items were developed based on literature review, clinician feedback, feasibility, and equipment and training needs. A standardized testing protocol and scoring rules were created. The MPS-PPM includes: Arm Function (7 items), Leg Function (5 items), and Endurance (2 items). Pilot data were collected for 10 subjects (ages 5-29 years). We calculated Spearman's rho correlations between age, severity and summary z-scores on the MPS-PPM. Results: Subjects had variable presentations, as correlations among the three sub-test scores were not significant. Increasing age was related to greater severity in physical performance (r = 0.72, p |
| doi_str_mv | 10.1080/13638490310001654763 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1080_13638490310001654763</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66650526</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-6616debf6810d0d6af910714aba9cc2c915b87282085567778929aeb43d3053c3</originalsourceid><addsrcrecordid>eNqFkMFKxDAQhoMorq6-gUhP3qqTpklTD4osri4s6EHPIU1TN0va1KRF-vZWd1EE0dPM4fv_GT6ETjCcY-BwgQkjPM2BYADAjKYZIzvoAGcUxzwlePdrT8gEHYawBmAjyPfRBNMEUsrJAZo_roZglLRRq33lfC0bpaNOh840L5FporpXrnV2CFKplfSmdMGEaHEZyag11nVR6PpyOEJ7lbRBH2_nFD3Pb59m9_Hy4W4xu1nGiiR5FzOGWamLinEMJZRMVjmGDKeykLlSicoxLXiW8AQ4pSzLMp4nudRFSkoClCgyRWeb3ta71378UtQmKG2tbLTrg2CMUaAJG8F0AyrvQvC6Eq03tfSDwCA-_Inf_I2x021_X9S6_A5thY3A9QYwzaetN-dtKTo5WOcrP8ozQZB_Tlz9aFhpabuVkl6Ltet9M-r7-8d3_yeQyA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66650526</pqid></control><display><type>article</type><title>Physical performance testing in mucopolysaccharidosis I: a pilot study</title><source>MEDLINE</source><source>Taylor & Francis</source><source>Taylor & Francis Medical Library - CRKN</source><creator>Dumas, Helene M. ; Fragala, Maria A. ; Haley, Stephen M. ; Skrinar, Alison M. ; Wraith, James E. ; Cox, Gerald F.</creator><creatorcontrib>Dumas, Helene M. ; Fragala, Maria A. ; Haley, Stephen M. ; Skrinar, Alison M. ; Wraith, James E. ; Cox, Gerald F.</creatorcontrib><description>Objective: To develop and field-test a physical performance measure (MPS-PPM) for individuals with Mucopolysaccharidosis I (MPS I), a rare genetic disorder. Methods: Motor performance and endurance items were developed based on literature review, clinician feedback, feasibility, and equipment and training needs. A standardized testing protocol and scoring rules were created. The MPS-PPM includes: Arm Function (7 items), Leg Function (5 items), and Endurance (2 items). Pilot data were collected for 10 subjects (ages 5-29 years). We calculated Spearman's rho correlations between age, severity and summary z-scores on the MPS-PPM. Results: Subjects had variable presentations, as correlations among the three sub-test scores were not significant. Increasing age was related to greater severity in physical performance (r = 0.72, p<0.05) and lower scores on the Leg Function (r = −0.67, p<0.05) and Endurance (r = −0.65, p<0.05) sub-tests. The MPS-PPM was sensitive to detecting physical performance deficits, as six subjects could not complete the full battery of Arm Function items and eight subjects were unable to complete all Leg Function items. Subjects walked more slowly and expended more energy than typically developing peers. Conclusions: Individuals with MPS I have difficulty with arm and leg function and reduced endurance. The MPS-PPM is a clinically feasible measure that detects limitations in physical performance and may have potential to quantify changes in function following intervention.</description><identifier>ISSN: 1751-8423</identifier><identifier>ISSN: 1363-8491</identifier><identifier>EISSN: 1751-8431</identifier><identifier>DOI: 10.1080/13638490310001654763</identifier><identifier>PMID: 15204583</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Adolescent ; Adult ; Child ; Child, Preschool ; children ; Energy Metabolism ; Female ; Humans ; Male ; Mucopolysaccharidosis I ; Mucopolysaccharidosis I - rehabilitation ; physical activity ; Pilot Projects ; Task Performance and Analysis ; testing ; youth</subject><ispartof>Developmental neurorehabilitation, 2004-04, Vol.7 (2), p.125-131</ispartof><rights>2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004</rights><rights>Copyright 2004 Taylor and Francis Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-6616debf6810d0d6af910714aba9cc2c915b87282085567778929aeb43d3053c3</citedby><cites>FETCH-LOGICAL-c329t-6616debf6810d0d6af910714aba9cc2c915b87282085567778929aeb43d3053c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/13638490310001654763$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/13638490310001654763$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,59623,59729,60412,60518,61197,61232,61378,61413</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15204583$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dumas, Helene M.</creatorcontrib><creatorcontrib>Fragala, Maria A.</creatorcontrib><creatorcontrib>Haley, Stephen M.</creatorcontrib><creatorcontrib>Skrinar, Alison M.</creatorcontrib><creatorcontrib>Wraith, James E.</creatorcontrib><creatorcontrib>Cox, Gerald F.</creatorcontrib><title>Physical performance testing in mucopolysaccharidosis I: a pilot study</title><title>Developmental neurorehabilitation</title><addtitle>Pediatr Rehabil</addtitle><description>Objective: To develop and field-test a physical performance measure (MPS-PPM) for individuals with Mucopolysaccharidosis I (MPS I), a rare genetic disorder. Methods: Motor performance and endurance items were developed based on literature review, clinician feedback, feasibility, and equipment and training needs. A standardized testing protocol and scoring rules were created. The MPS-PPM includes: Arm Function (7 items), Leg Function (5 items), and Endurance (2 items). Pilot data were collected for 10 subjects (ages 5-29 years). We calculated Spearman's rho correlations between age, severity and summary z-scores on the MPS-PPM. Results: Subjects had variable presentations, as correlations among the three sub-test scores were not significant. Increasing age was related to greater severity in physical performance (r = 0.72, p<0.05) and lower scores on the Leg Function (r = −0.67, p<0.05) and Endurance (r = −0.65, p<0.05) sub-tests. The MPS-PPM was sensitive to detecting physical performance deficits, as six subjects could not complete the full battery of Arm Function items and eight subjects were unable to complete all Leg Function items. Subjects walked more slowly and expended more energy than typically developing peers. Conclusions: Individuals with MPS I have difficulty with arm and leg function and reduced endurance. The MPS-PPM is a clinically feasible measure that detects limitations in physical performance and may have potential to quantify changes in function following intervention.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>children</subject><subject>Energy Metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Mucopolysaccharidosis I</subject><subject>Mucopolysaccharidosis I - rehabilitation</subject><subject>physical activity</subject><subject>Pilot Projects</subject><subject>Task Performance and Analysis</subject><subject>testing</subject><subject>youth</subject><issn>1751-8423</issn><issn>1363-8491</issn><issn>1751-8431</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFKxDAQhoMorq6-gUhP3qqTpklTD4osri4s6EHPIU1TN0va1KRF-vZWd1EE0dPM4fv_GT6ETjCcY-BwgQkjPM2BYADAjKYZIzvoAGcUxzwlePdrT8gEHYawBmAjyPfRBNMEUsrJAZo_roZglLRRq33lfC0bpaNOh840L5FporpXrnV2CFKplfSmdMGEaHEZyag11nVR6PpyOEJ7lbRBH2_nFD3Pb59m9_Hy4W4xu1nGiiR5FzOGWamLinEMJZRMVjmGDKeykLlSicoxLXiW8AQ4pSzLMp4nudRFSkoClCgyRWeb3ta71378UtQmKG2tbLTrg2CMUaAJG8F0AyrvQvC6Eq03tfSDwCA-_Inf_I2x021_X9S6_A5thY3A9QYwzaetN-dtKTo5WOcrP8ozQZB_Tlz9aFhpabuVkl6Ltet9M-r7-8d3_yeQyA</recordid><startdate>200404</startdate><enddate>200404</enddate><creator>Dumas, Helene M.</creator><creator>Fragala, Maria A.</creator><creator>Haley, Stephen M.</creator><creator>Skrinar, Alison M.</creator><creator>Wraith, James E.</creator><creator>Cox, Gerald F.</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200404</creationdate><title>Physical performance testing in mucopolysaccharidosis I: a pilot study</title><author>Dumas, Helene M. ; Fragala, Maria A. ; Haley, Stephen M. ; Skrinar, Alison M. ; Wraith, James E. ; Cox, Gerald F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-6616debf6810d0d6af910714aba9cc2c915b87282085567778929aeb43d3053c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>children</topic><topic>Energy Metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Mucopolysaccharidosis I</topic><topic>Mucopolysaccharidosis I - rehabilitation</topic><topic>physical activity</topic><topic>Pilot Projects</topic><topic>Task Performance and Analysis</topic><topic>testing</topic><topic>youth</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dumas, Helene M.</creatorcontrib><creatorcontrib>Fragala, Maria A.</creatorcontrib><creatorcontrib>Haley, Stephen M.</creatorcontrib><creatorcontrib>Skrinar, Alison M.</creatorcontrib><creatorcontrib>Wraith, James E.</creatorcontrib><creatorcontrib>Cox, Gerald F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Developmental neurorehabilitation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dumas, Helene M.</au><au>Fragala, Maria A.</au><au>Haley, Stephen M.</au><au>Skrinar, Alison M.</au><au>Wraith, James E.</au><au>Cox, Gerald F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physical performance testing in mucopolysaccharidosis I: a pilot study</atitle><jtitle>Developmental neurorehabilitation</jtitle><addtitle>Pediatr Rehabil</addtitle><date>2004-04</date><risdate>2004</risdate><volume>7</volume><issue>2</issue><spage>125</spage><epage>131</epage><pages>125-131</pages><issn>1751-8423</issn><issn>1363-8491</issn><eissn>1751-8431</eissn><abstract>Objective: To develop and field-test a physical performance measure (MPS-PPM) for individuals with Mucopolysaccharidosis I (MPS I), a rare genetic disorder. Methods: Motor performance and endurance items were developed based on literature review, clinician feedback, feasibility, and equipment and training needs. A standardized testing protocol and scoring rules were created. The MPS-PPM includes: Arm Function (7 items), Leg Function (5 items), and Endurance (2 items). Pilot data were collected for 10 subjects (ages 5-29 years). We calculated Spearman's rho correlations between age, severity and summary z-scores on the MPS-PPM. Results: Subjects had variable presentations, as correlations among the three sub-test scores were not significant. Increasing age was related to greater severity in physical performance (r = 0.72, p<0.05) and lower scores on the Leg Function (r = −0.67, p<0.05) and Endurance (r = −0.65, p<0.05) sub-tests. The MPS-PPM was sensitive to detecting physical performance deficits, as six subjects could not complete the full battery of Arm Function items and eight subjects were unable to complete all Leg Function items. Subjects walked more slowly and expended more energy than typically developing peers. Conclusions: Individuals with MPS I have difficulty with arm and leg function and reduced endurance. The MPS-PPM is a clinically feasible measure that detects limitations in physical performance and may have potential to quantify changes in function following intervention.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>15204583</pmid><doi>10.1080/13638490310001654763</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1751-8423 |
| ispartof | Developmental neurorehabilitation, 2004-04, Vol.7 (2), p.125-131 |
| issn | 1751-8423 1363-8491 1751-8431 |
| language | eng |
| recordid | cdi_informahealthcare_journals_10_1080_13638490310001654763 |
| source | MEDLINE; Taylor & Francis; Taylor & Francis Medical Library - CRKN |
| subjects | Adolescent Adult Child Child, Preschool children Energy Metabolism Female Humans Male Mucopolysaccharidosis I Mucopolysaccharidosis I - rehabilitation physical activity Pilot Projects Task Performance and Analysis testing youth |
| title | Physical performance testing in mucopolysaccharidosis I: a pilot study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T11%3A03%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physical%20performance%20testing%20in%20mucopolysaccharidosis%20I:%20a%20pilot%20study&rft.jtitle=Developmental%20neurorehabilitation&rft.au=Dumas,%20Helene%20M.&rft.date=2004-04&rft.volume=7&rft.issue=2&rft.spage=125&rft.epage=131&rft.pages=125-131&rft.issn=1751-8423&rft.eissn=1751-8431&rft_id=info:doi/10.1080/13638490310001654763&rft_dat=%3Cproquest_infor%3E66650526%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66650526&rft_id=info:pmid/15204583&rfr_iscdi=true |